BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 703450 Cc1ccc(cc1F)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15FN4O/c1-10-4-7-12(9-13(10)18)22-15-14(3-2-8-19-15)21-16(22)17(23)20-11-5-6-11/h2-4,7-9,11H,5-6H2,1H3,(H,20,23) HONSLVDJDKRIRK-UHFFFAOYSA-N 355723 N-Cyclopropyl-3-(3-fluoro-4-methylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 1 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 31.8 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355723 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355723&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 78322288 386395327 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703451 Cc1ccc(cc1F)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15FN4O/c1-10-4-7-12(9-13(10)18)22-15-14(3-2-8-19-15)21-16(22)17(23)20-11-5-6-11/h2-4,7-9,11H,5-6H2,1H3,(H,20,23) HONSLVDJDKRIRK-UHFFFAOYSA-N 355723 N-Cyclopropyl-3-(3-fluoro-4-methylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 1 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 2210 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355723 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355723&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 78322288 386395327 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703452 O=C(NC1CC1)c1nc2cccnc2n1C1CCCC1 InChI=1S/C15H18N4O/c20-15(17-10-7-8-10)14-18-12-6-3-9-16-13(12)19(14)11-4-1-2-5-11/h3,6,9-11H,1-2,4-5,7-8H2,(H,17,20) FGBXTYUGBFFINE-UHFFFAOYSA-N 355724 3-Cyclopentyl-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 2 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 426 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355724 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355724&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 78322289 386395328 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703453 O=C(NC1CC1)c1nc2cccnc2n1C1CCCC1 InChI=1S/C15H18N4O/c20-15(17-10-7-8-10)14-18-12-6-3-9-16-13(12)19(14)11-4-1-2-5-11/h3,6,9-11H,1-2,4-5,7-8H2,(H,17,20) FGBXTYUGBFFINE-UHFFFAOYSA-N 355724 3-Cyclopentyl-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 2 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 1270 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355724 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355724&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 78322289 386395328 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703454 Clc1ccc(cc1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H13ClN4O/c17-10-3-7-12(8-4-10)21-14-13(2-1-9-18-14)20-15(21)16(22)19-11-5-6-11/h1-4,7-9,11H,5-6H2,(H,19,22) FVZLDRBFELZMHB-UHFFFAOYSA-N 355725 3-(4-Chlorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 3 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 131 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355725 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355725&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 78322290 386395329 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703455 Clc1ccc(cc1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H13ClN4O/c17-10-3-7-12(8-4-10)21-14-13(2-1-9-18-14)20-15(21)16(22)19-11-5-6-11/h1-4,7-9,11H,5-6H2,(H,19,22) FVZLDRBFELZMHB-UHFFFAOYSA-N 355725 3-(4-Chlorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 3 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 7950 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355725 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355725&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 78322290 386395329 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703456 Fc1cc(ccc1Cl)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12ClFN4O/c17-11-6-5-10(8-12(11)18)22-14-13(2-1-7-19-14)21-15(22)16(23)20-9-3-4-9/h1-2,5-9H,3-4H2,(H,20,23) BPXDOOLHZUYSIJ-UHFFFAOYSA-N 355726 3-(4-Chloro-3-fluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 4 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 18.4 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355726 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355726&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 78322287 386395330 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703457 Fc1cc(ccc1Cl)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12ClFN4O/c17-11-6-5-10(8-12(11)18)22-14-13(2-1-7-19-14)21-15(22)16(23)20-9-3-4-9/h1-2,5-9H,3-4H2,(H,20,23) BPXDOOLHZUYSIJ-UHFFFAOYSA-N 355726 3-(4-Chloro-3-fluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 4 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 908 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355726 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355726&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 78322287 386395330 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703458 Cn1ccc(NC(=O)c2nc3cccnc3n2-c2ccc(Cl)c(F)c2)n1 InChI=1S/C17H12ClFN6O/c1-24-8-6-14(23-24)22-17(26)16-21-13-3-2-7-20-15(13)25(16)10-4-5-11(18)12(19)9-10/h2-9H,1H3,(H,22,23,26) MSMKCSNLKWZKCR-UHFFFAOYSA-N 355728 3-(4-Chloro-3-fluorophenyl)-N-(1-methyl-1H-pyrazol-3-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 5 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 54.1 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355728 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355728&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 78322291 386395332 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703459 Cn1ccc(NC(=O)c2nc3cccnc3n2-c2ccc(Cl)c(F)c2)n1 InChI=1S/C17H12ClFN6O/c1-24-8-6-14(23-24)22-17(26)16-21-13-3-2-7-20-15(13)25(16)10-4-5-11(18)12(19)9-10/h2-9H,1H3,(H,22,23,26) MSMKCSNLKWZKCR-UHFFFAOYSA-N 355728 3-(4-Chloro-3-fluorophenyl)-N-(1-methyl-1H-pyrazol-3-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 5 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 5640 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355728 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355728&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 78322291 386395332 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703460 CCCNC(=O)c1nc2cccnc2n1-c1ccc(Cl)c(F)c1 InChI=1S/C16H14ClFN4O/c1-2-7-20-16(23)15-21-13-4-3-8-19-14(13)22(15)10-5-6-11(17)12(18)9-10/h3-6,8-9H,2,7H2,1H3,(H,20,23) ZEXREJFXQICMKE-UHFFFAOYSA-N 355729 3-(4-Chloro-3-fluorophenyl)-N-propyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 6 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 38.1 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355729 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355729&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 78322292 386395333 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703461 CCCNC(=O)c1nc2cccnc2n1-c1ccc(Cl)c(F)c1 InChI=1S/C16H14ClFN4O/c1-2-7-20-16(23)15-21-13-4-3-8-19-14(13)22(15)10-5-6-11(17)12(18)9-10/h3-6,8-9H,2,7H2,1H3,(H,20,23) ZEXREJFXQICMKE-UHFFFAOYSA-N 355729 3-(4-Chloro-3-fluorophenyl)-N-propyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 6 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 778 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355729 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355729&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 78322292 386395333 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703462 Fc1cc(ccc1C#N)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H12FN5O/c18-13-8-12(6-3-10(13)9-19)23-15-14(2-1-7-20-15)22-16(23)17(24)21-11-4-5-11/h1-3,6-8,11H,4-5H2,(H,21,24) GLEHUWJERNYRED-UHFFFAOYSA-N 355730 3-(4-Cyano-3-fluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 7 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 40.8 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355730 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355730&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 78322293 386395334 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703463 Fc1cc(ccc1C#N)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H12FN5O/c18-13-8-12(6-3-10(13)9-19)23-15-14(2-1-7-20-15)22-16(23)17(24)21-11-4-5-11/h1-3,6-8,11H,4-5H2,(H,21,24) GLEHUWJERNYRED-UHFFFAOYSA-N 355730 3-(4-Cyano-3-fluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 7 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 1880 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355730 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355730&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 78322293 386395334 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703464 Fc1cc(ccc1C#N)-n1c(nc2cccnc12)C(=O)N1CCC1 InChI=1S/C17H12FN5O/c18-13-9-12(5-4-11(13)10-19)23-15-14(3-1-6-20-15)21-16(23)17(24)22-7-2-8-22/h1,3-6,9H,2,7-8H2 FHQCTSOHGYCCMK-UHFFFAOYSA-N 355731 4-[2-(Azetidin-1-ylcarbonyl)-3H-imidazo[4,5-b]pyridin-3-yl]-2-fluorobenzonitrile::US9815832, 8 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 16.0 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355731 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355731&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 78322294 386395335 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703465 Fc1cc(ccc1C#N)-n1c(nc2cccnc12)C(=O)N1CCC1 InChI=1S/C17H12FN5O/c18-13-9-12(5-4-11(13)10-19)23-15-14(3-1-6-20-15)21-16(23)17(24)22-7-2-8-22/h1,3-6,9H,2,7-8H2 FHQCTSOHGYCCMK-UHFFFAOYSA-N 355731 4-[2-(Azetidin-1-ylcarbonyl)-3H-imidazo[4,5-b]pyridin-3-yl]-2-fluorobenzonitrile::US9815832, 8 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 910 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355731 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355731&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 78322294 386395335 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703466 Fc1cc(cc(F)c1Cl)-n1c(nc2cccnc12)C(=O)N1CCC1 InChI=1S/C16H11ClF2N4O/c17-13-10(18)7-9(8-11(13)19)23-14-12(3-1-4-20-14)21-15(23)16(24)22-5-2-6-22/h1,3-4,7-8H,2,5-6H2 RJRKJHOEVRBWEF-UHFFFAOYSA-N 355732 Azetidin-1-yl[3-(4-chloro-3,5-difluorophenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methanone::US9815832, 9 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 14.2 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355732 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355732&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 78322600 386395336 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703467 Fc1cc(cc(F)c1Cl)-n1c(nc2cccnc12)C(=O)N1CCC1 InChI=1S/C16H11ClF2N4O/c17-13-10(18)7-9(8-11(13)19)23-14-12(3-1-4-20-14)21-15(23)16(24)22-5-2-6-22/h1,3-4,7-8H,2,5-6H2 RJRKJHOEVRBWEF-UHFFFAOYSA-N 355732 Azetidin-1-yl[3-(4-chloro-3,5-difluorophenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methanone::US9815832, 9 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 420 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355732 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355732&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 78322600 386395336 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703468 Fc1cc(ccc1Cl)-n1c(nc2cccnc12)C(Cl)(Cl)Cl InChI=1S/C13H6Cl4FN3/c14-8-4-3-7(6-9(8)18)21-11-10(2-1-5-19-11)20-12(21)13(15,16)17/h1-6H IFYQCBSGYXYNJT-UHFFFAOYSA-N 355733 Azetidin-1-yl[3-(4-chloro-3-fluorophenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methanone::US9815832, 10 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 15.2 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355733 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355733&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 86730074 386395337 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703469 Fc1cc(ccc1Cl)-n1c(nc2cccnc12)C(Cl)(Cl)Cl InChI=1S/C13H6Cl4FN3/c14-8-4-3-7(6-9(8)18)21-11-10(2-1-5-19-11)20-12(21)13(15,16)17/h1-6H IFYQCBSGYXYNJT-UHFFFAOYSA-N 355733 Azetidin-1-yl[3-(4-chloro-3-fluorophenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methanone::US9815832, 10 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 567 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355733 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355733&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 86730074 386395337 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703470 CN(C)C(=O)c1nc2cccnc2n1-c1ccc(Cl)c(F)c1 InChI=1S/C15H12ClFN4O/c1-20(2)15(22)14-19-12-4-3-7-18-13(12)21(14)9-5-6-10(16)11(17)8-9/h3-8H,1-2H3 KEIPOWWGIVMTTO-UHFFFAOYSA-N 355734 3-(4-Chloro-3-fluorophenyl)-N,N-dimethyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 11 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 405 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355734 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355734&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 78322602 386395338 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703471 CN(C)C(=O)c1nc2cccnc2n1-c1ccc(Cl)c(F)c1 InChI=1S/C15H12ClFN4O/c1-20(2)15(22)14-19-12-4-3-7-18-13(12)21(14)9-5-6-10(16)11(17)8-9/h3-8H,1-2H3 KEIPOWWGIVMTTO-UHFFFAOYSA-N 355734 3-(4-Chloro-3-fluorophenyl)-N,N-dimethyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 11 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 9640 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355734 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355734&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 78322602 386395338 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703472 Fc1cc(c(F)cc1Cl)-n1c(nc2cccnc12)C(=O)N1CCC1 InChI=1S/C16H11ClF2N4O/c17-9-7-11(19)13(8-10(9)18)23-14-12(3-1-4-20-14)21-15(23)16(24)22-5-2-6-22/h1,3-4,7-8H,2,5-6H2 XSRUKFNHJGPNOA-UHFFFAOYSA-N 355735 Azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methanone, trifluoroacetate salt::US9815832, 12 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 99.4 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355735 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355735&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 78322603 386395339 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703473 Fc1cc(c(F)cc1Cl)-n1c(nc2cccnc12)C(=O)N1CCC1 InChI=1S/C16H11ClF2N4O/c17-9-7-11(19)13(8-10(9)18)23-14-12(3-1-4-20-14)21-15(23)16(24)22-5-2-6-22/h1,3-4,7-8H,2,5-6H2 XSRUKFNHJGPNOA-UHFFFAOYSA-N 355735 Azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methanone, trifluoroacetate salt::US9815832, 12 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 1520 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355735 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355735&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 78322603 386395339 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703474 CCCNC(=O)c1nc2cccnc2n1-c1ccc(Cl)cc1 InChI=1S/C16H15ClN4O/c1-2-9-19-16(22)15-20-13-4-3-10-18-14(13)21(15)12-7-5-11(17)6-8-12/h3-8,10H,2,9H2,1H3,(H,19,22) DXAVXHTZVPUHRI-UHFFFAOYSA-N 355736 3-(4-Chlorophenyl)-N-propyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 13 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 944 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355736 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355736&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343352 386395340 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703475 CCCNC(=O)c1nc2cccnc2n1-c1ccc(Cl)cc1 InChI=1S/C16H15ClN4O/c1-2-9-19-16(22)15-20-13-4-3-10-18-14(13)21(15)12-7-5-11(17)6-8-12/h3-8,10H,2,9H2,1H3,(H,19,22) DXAVXHTZVPUHRI-UHFFFAOYSA-N 355736 3-(4-Chlorophenyl)-N-propyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 13 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 6640 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355736 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355736&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343352 386395340 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703476 Cn1ccc(NC(=O)c2nc3cccnc3n2C2CCCC2)n1 InChI=1S/C16H18N6O/c1-21-10-8-13(20-21)19-16(23)15-18-12-7-4-9-17-14(12)22(15)11-5-2-3-6-11/h4,7-11H,2-3,5-6H2,1H3,(H,19,20,23) OVWRKLUBWLETTN-UHFFFAOYSA-N 355737 3-Cyclopentyl-N-(1-methyl-1H-pyrazol-3-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 14 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 822 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355737 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355737&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 78322604 386395341 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703477 Cn1ccc(NC(=O)c2nc3cccnc3n2C2CCCC2)n1 InChI=1S/C16H18N6O/c1-21-10-8-13(20-21)19-16(23)15-18-12-7-4-9-17-14(12)22(15)11-5-2-3-6-11/h4,7-11H,2-3,5-6H2,1H3,(H,19,20,23) OVWRKLUBWLETTN-UHFFFAOYSA-N 355737 3-Cyclopentyl-N-(1-methyl-1H-pyrazol-3-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 14 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 4380 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355737 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355737&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 78322604 386395341 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703478 O=C(NC1CC1)c1nc2cccnc2n1C1CCOCC1 InChI=1S/C15H18N4O2/c20-15(17-10-3-4-10)14-18-12-2-1-7-16-13(12)19(14)11-5-8-21-9-6-11/h1-2,7,10-11H,3-6,8-9H2,(H,17,20) QJNQMSOBPOEFSP-UHFFFAOYSA-N 355738 N-Cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 15 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 1730 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355738 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355738&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 78322605 386395342 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703479 O=C(NC1CC1)c1nc2cccnc2n1C1CCOCC1 InChI=1S/C15H18N4O2/c20-15(17-10-3-4-10)14-18-12-2-1-7-16-13(12)19(14)11-5-8-21-9-6-11/h1-2,7,10-11H,3-6,8-9H2,(H,17,20) QJNQMSOBPOEFSP-UHFFFAOYSA-N 355738 N-Cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 15 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 6900 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355738 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355738&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 78322605 386395342 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703480 Clc1ccc(cc1)-n1c(nc2cccnc12)C(=O)N1CCC1 InChI=1S/C16H13ClN4O/c17-11-4-6-12(7-5-11)21-14-13(3-1-8-18-14)19-15(21)16(22)20-9-2-10-20/h1,3-8H,2,9-10H2 QRSRFQGRYZHZLU-UHFFFAOYSA-N 355739 Azetidin-1-yl[3-(4-chlorophenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methanone::US9815832, 16 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 196 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355739 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355739&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 78322606 386395343 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703481 Clc1ccc(cc1)-n1c(nc2cccnc12)C(=O)N1CCC1 InChI=1S/C16H13ClN4O/c17-11-4-6-12(7-5-11)21-14-13(3-1-8-18-14)19-15(21)16(22)20-9-2-10-20/h1,3-8H,2,9-10H2 QRSRFQGRYZHZLU-UHFFFAOYSA-N 355739 Azetidin-1-yl[3-(4-chlorophenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methanone::US9815832, 16 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 5500 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355739 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355739&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 78322606 386395343 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703482 NC(=O)c1nc2cccnc2n1-c1ccc(Cl)c(F)c1 InChI=1S/C13H8ClFN4O/c14-8-4-3-7(6-9(8)15)19-12-10(2-1-5-17-12)18-13(19)11(16)20/h1-6H,(H2,16,20) NTELJMOMERGOFH-UHFFFAOYSA-N 355740 3-(4-Chloro-3-fluorophenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 17 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 8510 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355740 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355740&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343130 386395344 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703483 NC(=O)c1nc2cccnc2n1-c1ccc(Cl)c(F)c1 InChI=1S/C13H8ClFN4O/c14-8-4-3-7(6-9(8)15)19-12-10(2-1-5-17-12)18-13(19)11(16)20/h1-6H,(H2,16,20) NTELJMOMERGOFH-UHFFFAOYSA-N 355740 3-(4-Chloro-3-fluorophenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 17 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >30000 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355740 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355740&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343130 386395344 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703484 Cc1ccc(cc1F)-n1c(nc2cccnc12)C(=O)N1CCC1 InChI=1S/C17H15FN4O/c1-11-5-6-12(10-13(11)18)22-15-14(4-2-7-19-15)20-16(22)17(23)21-8-3-9-21/h2,4-7,10H,3,8-9H2,1H3 WQUXLZDKVSHSAC-UHFFFAOYSA-N 355741 Azetidin-1-yl[3-(3-fluoro-4-methylphenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methanone::US9815832, 18 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 48.7 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355741 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355741&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343170 386395345 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703485 Cc1ccc(cc1F)-n1c(nc2cccnc12)C(=O)N1CCC1 InChI=1S/C17H15FN4O/c1-11-5-6-12(10-13(11)18)22-15-14(4-2-7-19-15)20-16(22)17(23)21-8-3-9-21/h2,4-7,10H,3,8-9H2,1H3 WQUXLZDKVSHSAC-UHFFFAOYSA-N 355741 Azetidin-1-yl[3-(3-fluoro-4-methylphenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methanone::US9815832, 18 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 2140 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355741 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355741&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343170 386395345 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703486 Cc1ccc(cc1F)-n1c(nc2cccnc12)C(=O)N1CC(F)C1 InChI=1S/C17H14F2N4O/c1-10-4-5-12(7-13(10)19)23-15-14(3-2-6-20-15)21-16(23)17(24)22-8-11(18)9-22/h2-7,11H,8-9H2,1H3 LNRUIUIHQCBHFP-UHFFFAOYSA-N 355742 (3-Fluoroazetidin-1-yl)[3-(3-fluoro-4-methylphenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methanone::US9815832, 19 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 281 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355742 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355742&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90352323 386395346 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703487 Cc1ccc(cc1F)-n1c(nc2cccnc12)C(=O)N1CC(F)C1 InChI=1S/C17H14F2N4O/c1-10-4-5-12(7-13(10)19)23-15-14(3-2-6-20-15)21-16(23)17(24)22-8-11(18)9-22/h2-7,11H,8-9H2,1H3 LNRUIUIHQCBHFP-UHFFFAOYSA-N 355742 (3-Fluoroazetidin-1-yl)[3-(3-fluoro-4-methylphenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methanone::US9815832, 19 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 5280 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355742 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355742&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90352323 386395346 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703488 Fc1cc(cc(F)c1C#N)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H11F2N5O/c18-12-6-10(7-13(19)11(12)8-20)24-15-14(2-1-5-21-15)23-16(24)17(25)22-9-3-4-9/h1-2,5-7,9H,3-4H2,(H,22,25) AGVGVGRMVVPSRJ-UHFFFAOYSA-N 355743 3-(4-Cyano-3,5-difluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 20 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 13.8 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355743 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355743&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 78322607 386395347 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703489 Fc1cc(cc(F)c1C#N)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H11F2N5O/c18-12-6-10(7-13(19)11(12)8-20)24-15-14(2-1-5-21-15)23-16(24)17(25)22-9-3-4-9/h1-2,5-7,9H,3-4H2,(H,22,25) AGVGVGRMVVPSRJ-UHFFFAOYSA-N 355743 3-(4-Cyano-3,5-difluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 20 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 262 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355743 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355743&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 78322607 386395347 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703490 FC1CN(C1)C(=O)c1nc2cccnc2n1-c1ccc(Cl)c(F)c1 InChI=1S/C16H11ClF2N4O/c17-11-4-3-10(6-12(11)19)23-14-13(2-1-5-20-14)21-15(23)16(24)22-7-9(18)8-22/h1-6,9H,7-8H2 FLCQAEUNWDIZPW-UHFFFAOYSA-N 355744 US9815832, 21::[3-(4-Chloro-3-fluorophenyl)-3H-imidazo[4,5-b]pyridin-2-yl](3-fluoroazetidin-1-yl)methanone cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 42.6 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355744 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355744&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343462 386395348 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703491 FC1CN(C1)C(=O)c1nc2cccnc2n1-c1ccc(Cl)c(F)c1 InChI=1S/C16H11ClF2N4O/c17-11-4-3-10(6-12(11)19)23-14-13(2-1-5-20-14)21-15(23)16(24)22-7-9(18)8-22/h1-6,9H,7-8H2 FLCQAEUNWDIZPW-UHFFFAOYSA-N 355744 US9815832, 21::[3-(4-Chloro-3-fluorophenyl)-3H-imidazo[4,5-b]pyridin-2-yl](3-fluoroazetidin-1-yl)methanone cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 316 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355744 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355744&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343462 386395348 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703492 Fc1cc(Cl)ccc1-n1c(nc2cccnc12)C(=O)N1CCC1 InChI=1S/C16H12ClFN4O/c17-10-4-5-13(11(18)9-10)22-14-12(3-1-6-19-14)20-15(22)16(23)21-7-2-8-21/h1,3-6,9H,2,7-8H2 LAIGXPCAYTWYHF-UHFFFAOYSA-N 355745 Azetidin-1-yl[3-(4-chloro-2-fluorophenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methanone::US9815832, 22 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 273 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355745 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355745&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 78322911 386395349 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703493 Fc1cc(Cl)ccc1-n1c(nc2cccnc12)C(=O)N1CCC1 InChI=1S/C16H12ClFN4O/c17-10-4-5-13(11(18)9-10)22-14-12(3-1-6-19-14)20-15(22)16(23)21-7-2-8-21/h1,3-6,9H,2,7-8H2 LAIGXPCAYTWYHF-UHFFFAOYSA-N 355745 Azetidin-1-yl[3-(4-chloro-2-fluorophenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methanone::US9815832, 22 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 5590 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355745 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355745&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 78322911 386395349 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703494 Fc1cc(Cl)ccc1-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12ClFN4O/c17-9-3-6-13(11(18)8-9)22-14-12(2-1-7-19-14)21-15(22)16(23)20-10-4-5-10/h1-3,6-8,10H,4-5H2,(H,20,23) JPYAMLLEZNRELS-UHFFFAOYSA-N 355746 3-(4-Chloro-2-fluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 23 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 632 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355746 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355746&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343154 386395350 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703495 Fc1cc(Cl)ccc1-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12ClFN4O/c17-9-3-6-13(11(18)8-9)22-14-12(2-1-7-19-14)21-15(22)16(23)20-10-4-5-10/h1-3,6-8,10H,4-5H2,(H,20,23) JPYAMLLEZNRELS-UHFFFAOYSA-N 355746 3-(4-Chloro-2-fluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 23 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >30000 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355746 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355746&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343154 386395350 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703496 Cn1ccc(NC(=O)c2nc3cccnc3n2-c2ccc(Cl)cc2)n1 InChI=1S/C17H13ClN6O/c1-23-10-8-14(22-23)21-17(25)16-20-13-3-2-9-19-15(13)24(16)12-6-4-11(18)5-7-12/h2-10H,1H3,(H,21,22,25) RXJCZZJQOCCAFB-UHFFFAOYSA-N 355747 3-(4-Chlorophenyl)-N-(1-methyl-1H-pyrazol-3-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 24 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 211 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355747 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355747&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 78322912 386395351 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703497 Cn1ccc(NC(=O)c2nc3cccnc3n2-c2ccc(Cl)cc2)n1 InChI=1S/C17H13ClN6O/c1-23-10-8-14(22-23)21-17(25)16-20-13-3-2-9-19-15(13)24(16)12-6-4-11(18)5-7-12/h2-10H,1H3,(H,21,22,25) RXJCZZJQOCCAFB-UHFFFAOYSA-N 355747 3-(4-Chlorophenyl)-N-(1-methyl-1H-pyrazol-3-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 24 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >24100 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355747 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355747&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 78322912 386395351 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703498 FC1CN(C1)C(=O)c1nc2cccnc2n1-c1ccc(Cl)cc1F InChI=1S/C16H11ClF2N4O/c17-9-3-4-13(11(19)6-9)23-14-12(2-1-5-20-14)21-15(23)16(24)22-7-10(18)8-22/h1-6,10H,7-8H2 CZGUHENSKPTIOB-UHFFFAOYSA-N 355748 US9815832, 25::[3-(4-Chloro-2-fluorophenyl)-3H-imidazo[4,5-b]pyridin-2-yl](3-fluoroazetidin-1-yl)methanone cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 910 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355748 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355748&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 78322913 386395352 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703499 FC1CN(C1)C(=O)c1nc2cccnc2n1-c1ccc(Cl)cc1F InChI=1S/C16H11ClF2N4O/c17-9-3-4-13(11(19)6-9)23-14-12(2-1-5-20-14)21-15(23)16(24)22-7-10(18)8-22/h1-6,10H,7-8H2 CZGUHENSKPTIOB-UHFFFAOYSA-N 355748 US9815832, 25::[3-(4-Chloro-2-fluorophenyl)-3H-imidazo[4,5-b]pyridin-2-yl](3-fluoroazetidin-1-yl)methanone cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 5840 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355748 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355748&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 78322913 386395352 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703500 Cc1cc(Cl)ccc1-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15ClN4O/c1-10-9-11(18)4-7-14(10)22-15-13(3-2-8-19-15)21-16(22)17(23)20-12-5-6-12/h2-4,7-9,12H,5-6H2,1H3,(H,20,23) QDXDJUKHXSVGLR-UHFFFAOYSA-N 355749 3-(4-Chloro-2-methylphenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 26 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 319 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355749 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355749&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343639 386395353 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703501 Cc1cc(Cl)ccc1-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15ClN4O/c1-10-9-11(18)4-7-14(10)22-15-13(3-2-8-19-15)21-16(22)17(23)20-12-5-6-12/h2-4,7-9,12H,5-6H2,1H3,(H,20,23) QDXDJUKHXSVGLR-UHFFFAOYSA-N 355749 3-(4-Chloro-2-methylphenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 26 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >17900 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355749 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355749&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343639 386395353 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703502 Clc1ccc(cc1Cl)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12Cl2N4O/c17-11-6-5-10(8-12(11)18)22-14-13(2-1-7-19-14)21-15(22)16(23)20-9-3-4-9/h1-2,5-9H,3-4H2,(H,20,23) LZTJYRYBQLTRFF-UHFFFAOYSA-N 355750 N-Cyclopropyl-3-(3,4-dichlorophenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 27 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 12.2 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355750 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355750&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343287 386395354 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703503 Clc1ccc(cc1Cl)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12Cl2N4O/c17-11-6-5-10(8-12(11)18)22-14-13(2-1-7-19-14)21-15(22)16(23)20-9-3-4-9/h1-2,5-9H,3-4H2,(H,20,23) LZTJYRYBQLTRFF-UHFFFAOYSA-N 355750 N-Cyclopropyl-3-(3,4-dichlorophenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 27 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 511 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355750 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355750&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343287 386395354 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703504 Cc1cc(ccc1F)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15FN4O/c1-10-9-12(6-7-13(10)18)22-15-14(3-2-8-19-15)21-16(22)17(23)20-11-4-5-11/h2-3,6-9,11H,4-5H2,1H3,(H,20,23) IHLXVESVKLWHAW-UHFFFAOYSA-N 355751 N-Cyclopropyl-3-(4-fluoro-3-methylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 28 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 114 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355751 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355751&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343090 386395355 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703505 Cc1cc(ccc1F)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15FN4O/c1-10-9-12(6-7-13(10)18)22-15-14(3-2-8-19-15)21-16(22)17(23)20-11-4-5-11/h2-3,6-9,11H,4-5H2,1H3,(H,20,23) IHLXVESVKLWHAW-UHFFFAOYSA-N 355751 N-Cyclopropyl-3-(4-fluoro-3-methylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 28 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 8230 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355751 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355751&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343090 386395355 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703506 Cc1ccc(cc1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H16N4O/c1-11-4-8-13(9-5-11)21-15-14(3-2-10-18-15)20-16(21)17(22)19-12-6-7-12/h2-5,8-10,12H,6-7H2,1H3,(H,19,22) ZGCPVXLZLLWOLS-UHFFFAOYSA-N 355752 N-Cyclopropyl-3-(4-methylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 29 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 225 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355752 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355752&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343027 386395356 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703507 Cc1ccc(cc1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H16N4O/c1-11-4-8-13(9-5-11)21-15-14(3-2-10-18-15)20-16(21)17(22)19-12-6-7-12/h2-5,8-10,12H,6-7H2,1H3,(H,19,22) ZGCPVXLZLLWOLS-UHFFFAOYSA-N 355752 N-Cyclopropyl-3-(4-methylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 29 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >28000 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355752 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355752&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343027 386395356 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703508 Fc1cc(cc(F)c1F)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H11F3N4O/c17-10-6-9(7-11(18)13(10)19)23-14-12(2-1-5-20-14)22-15(23)16(24)21-8-3-4-8/h1-2,5-8H,3-4H2,(H,21,24) DVBOFLIQQHYFJF-UHFFFAOYSA-N 355753 N-Cyclopropyl-3-(3,4,5-trifluorophenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide,trifluoroacetate salt::US9815832, 30 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 5.77 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355753 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355753&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90352324 386395357 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703509 Fc1cc(cc(F)c1F)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H11F3N4O/c17-10-6-9(7-11(18)13(10)19)23-14-12(2-1-5-20-14)22-15(23)16(24)21-8-3-4-8/h1-2,5-8H,3-4H2,(H,21,24) DVBOFLIQQHYFJF-UHFFFAOYSA-N 355753 N-Cyclopropyl-3-(3,4,5-trifluorophenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide,trifluoroacetate salt::US9815832, 30 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 333 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355753 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355753&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90352324 386395357 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703510 Fc1ccc(cc1C#N)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H12FN5O/c18-13-6-5-12(8-10(13)9-19)23-15-14(2-1-7-20-15)22-16(23)17(24)21-11-3-4-11/h1-2,5-8,11H,3-4H2,(H,21,24) NTQPCQRPHWXGAT-UHFFFAOYSA-N 355754 3-(3-Cyano-4-fluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 31 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 87.5 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355754 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355754&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342944 386395358 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703511 Fc1ccc(cc1C#N)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H12FN5O/c18-13-6-5-12(8-10(13)9-19)23-15-14(2-1-7-20-15)22-16(23)17(24)21-11-3-4-11/h1-2,5-8,11H,3-4H2,(H,21,24) NTQPCQRPHWXGAT-UHFFFAOYSA-N 355754 3-(3-Cyano-4-fluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 31 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 2550 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355754 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355754&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342944 386395358 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703512 Fc1ccc(cc1Cl)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12ClFN4O/c17-11-8-10(5-6-12(11)18)22-14-13(2-1-7-19-14)21-15(22)16(23)20-9-3-4-9/h1-2,5-9H,3-4H2,(H,20,23) ZVFTUROJCXRDLE-UHFFFAOYSA-N 355755 3-(3-Chloro-4-fluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 32 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 15.7 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355755 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355755&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343196 386395359 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703513 Fc1ccc(cc1Cl)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12ClFN4O/c17-11-8-10(5-6-12(11)18)22-14-13(2-1-7-19-14)21-15(22)16(23)20-9-3-4-9/h1-2,5-9H,3-4H2,(H,20,23) ZVFTUROJCXRDLE-UHFFFAOYSA-N 355755 3-(3-Chloro-4-fluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 32 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 886 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355755 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355755&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343196 386395359 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703514 Cc1ccc(cc1Cl)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15ClN4O/c1-10-4-7-12(9-13(10)18)22-15-14(3-2-8-19-15)21-16(22)17(23)20-11-5-6-11/h2-4,7-9,11H,5-6H2,1H3,(H,20,23) WMHAFHPEFGQMEO-UHFFFAOYSA-N 355756 3-(3-Chloro-4-methylphenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 33 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 15.9 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355756&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343271 386395360 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703515 Cc1ccc(cc1Cl)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15ClN4O/c1-10-4-7-12(9-13(10)18)22-15-14(3-2-8-19-15)21-16(22)17(23)20-11-5-6-11/h2-4,7-9,11H,5-6H2,1H3,(H,20,23) WMHAFHPEFGQMEO-UHFFFAOYSA-N 355756 3-(3-Chloro-4-methylphenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 33 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 1230 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355756&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343271 386395360 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703516 Cc1cc(Cl)ccc1-n1c(nc2cccnc12)C(=O)N1CCC1 InChI=1S/C17H15ClN4O/c1-11-10-12(18)5-6-14(11)22-15-13(4-2-7-19-15)20-16(22)17(23)21-8-3-9-21/h2,4-7,10H,3,8-9H2,1H3 AQVBHMLPJHPONG-UHFFFAOYSA-N 355757 Azetidin-1-yl[3-(4-chloro-2-methylphenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methanone::US9815832, 34 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 399 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355757&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343392 386395361 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703517 Cc1cc(Cl)ccc1-n1c(nc2cccnc12)C(=O)N1CCC1 InChI=1S/C17H15ClN4O/c1-11-10-12(18)5-6-14(11)22-15-13(4-2-7-19-15)20-16(22)17(23)21-8-3-9-21/h2,4-7,10H,3,8-9H2,1H3 AQVBHMLPJHPONG-UHFFFAOYSA-N 355757 Azetidin-1-yl[3-(4-chloro-2-methylphenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methanone::US9815832, 34 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 10200 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355757&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343392 386395361 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703518 Cc1cc(Cl)ccc1-n1c(nc2cccnc12)C(=O)N1CC(F)C1 InChI=1S/C17H14ClFN4O/c1-10-7-11(18)4-5-14(10)23-15-13(3-2-6-20-15)21-16(23)17(24)22-8-12(19)9-22/h2-7,12H,8-9H2,1H3 CXZUOXZJBLTMDE-UHFFFAOYSA-N 355758 US9815832, 35::[3-(4-Chloro-2-methylphenyl)-3H-imidazo[4,5-b]pyridin-2-yl](3-fluoroazetidin-1-yl)methanone cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 1130 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355758 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355758&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342819 386395362 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703519 Cc1cc(Cl)ccc1-n1c(nc2cccnc12)C(=O)N1CC(F)C1 InChI=1S/C17H14ClFN4O/c1-10-7-11(18)4-5-14(10)23-15-13(3-2-6-20-15)21-16(23)17(24)22-8-12(19)9-22/h2-7,12H,8-9H2,1H3 CXZUOXZJBLTMDE-UHFFFAOYSA-N 355758 US9815832, 35::[3-(4-Chloro-2-methylphenyl)-3H-imidazo[4,5-b]pyridin-2-yl](3-fluoroazetidin-1-yl)methanone cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 8280 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355758 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355758&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342819 386395362 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703520 Fc1cc(cc(F)c1Cl)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H11ClF2N4O/c17-13-10(18)6-9(7-11(13)19)23-14-12(2-1-5-20-14)22-15(23)16(24)21-8-3-4-8/h1-2,5-8H,3-4H2,(H,21,24) QJAZNBXYYNAKDQ-UHFFFAOYSA-N 355759 3-(4-Chloro-3,5-difluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 36 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 5.65 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355759 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355759&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 77050784 386395363 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703521 Fc1cc(cc(F)c1Cl)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H11ClF2N4O/c17-13-10(18)6-9(7-11(13)19)23-14-12(2-1-5-20-14)22-15(23)16(24)21-8-3-4-8/h1-2,5-8H,3-4H2,(H,21,24) QJAZNBXYYNAKDQ-UHFFFAOYSA-N 355759 3-(4-Chloro-3,5-difluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 36 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 255 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355759 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355759&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 77050784 386395363 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703522 Clc1cncc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C15H12ClN5O/c16-9-6-11(8-17-7-9)21-13-12(2-1-5-18-13)20-14(21)15(22)19-10-3-4-10/h1-2,5-8,10H,3-4H2,(H,19,22) ATQGIPKMMLFBDU-UHFFFAOYSA-N 355760 3-(5-Chloropyridin-3-yl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 37 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 409 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355760 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355760&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342732 386395364 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703523 Clc1cncc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C15H12ClN5O/c16-9-6-11(8-17-7-9)21-13-12(2-1-5-18-13)20-14(21)15(22)19-10-3-4-10/h1-2,5-8,10H,3-4H2,(H,19,22) ATQGIPKMMLFBDU-UHFFFAOYSA-N 355760 3-(5-Chloropyridin-3-yl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 37 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 10700 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355760 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355760&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342732 386395364 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703524 Clc1cncc(c1)-n1c(nc2cccnc12)C(=O)N1CCC1 InChI=1S/C15H12ClN5O/c16-10-7-11(9-17-8-10)21-13-12(3-1-4-18-13)19-14(21)15(22)20-5-2-6-20/h1,3-4,7-9H,2,5-6H2 KLSIXALMZFSBHM-UHFFFAOYSA-N 355761 Azetidin-1-yl[3-(5-chloropyridin-3-yl)-3H-imidazo[4,5-b]pyridin-2-yl]methanone::US9815832, 38 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 466 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355761 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355761&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343129 386395365 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703525 Clc1cncc(c1)-n1c(nc2cccnc12)C(=O)N1CCC1 InChI=1S/C15H12ClN5O/c16-10-7-11(9-17-8-10)21-13-12(3-1-4-18-13)19-14(21)15(22)20-5-2-6-20/h1,3-4,7-9H,2,5-6H2 KLSIXALMZFSBHM-UHFFFAOYSA-N 355761 Azetidin-1-yl[3-(5-chloropyridin-3-yl)-3H-imidazo[4,5-b]pyridin-2-yl]methanone::US9815832, 38 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 6670 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355761 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355761&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343129 386395365 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703526 O=C(NC1CC1)c1nc2cccnc2n1-c1ccc(nc1)C#N InChI=1S/C16H12N6O/c17-8-11-5-6-12(9-19-11)22-14-13(2-1-7-18-14)21-15(22)16(23)20-10-3-4-10/h1-2,5-7,9-10H,3-4H2,(H,20,23) FTTBKJRFLWYFPV-UHFFFAOYSA-N 355762 3-(6-Cyanopyridin-3-yl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 39 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 363 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355762&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343035 386395366 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703527 O=C(NC1CC1)c1nc2cccnc2n1-c1ccc(nc1)C#N InChI=1S/C16H12N6O/c17-8-11-5-6-12(9-19-11)22-14-13(2-1-7-18-14)21-15(22)16(23)20-10-3-4-10/h1-2,5-7,9-10H,3-4H2,(H,20,23) FTTBKJRFLWYFPV-UHFFFAOYSA-N 355762 3-(6-Cyanopyridin-3-yl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 39 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 10200 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355762&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343035 386395366 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703528 Fc1ccc(cc1-n1c(nc2cccnc12)C(=O)NC1CC1)C#N InChI=1S/C17H12FN5O/c18-12-6-3-10(9-19)8-14(12)23-15-13(2-1-7-20-15)22-16(23)17(24)21-11-4-5-11/h1-3,6-8,11H,4-5H2,(H,21,24) RXHGAQRVTQOHKM-UHFFFAOYSA-N 355763 3-(5-Cyano-2-fluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 40 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 1710 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355763 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355763&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343042 386395367 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703529 Fc1ccc(cc1-n1c(nc2cccnc12)C(=O)NC1CC1)C#N InChI=1S/C17H12FN5O/c18-12-6-3-10(9-19)8-14(12)23-15-13(2-1-7-20-15)22-16(23)17(24)21-11-4-5-11/h1-3,6-8,11H,4-5H2,(H,21,24) RXHGAQRVTQOHKM-UHFFFAOYSA-N 355763 3-(5-Cyano-2-fluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 40 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 15200 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355763 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355763&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343042 386395367 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703530 Fc1cc(c(F)cc1Cl)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H11ClF2N4O/c17-9-6-11(19)13(7-10(9)18)23-14-12(2-1-5-20-14)22-15(23)16(24)21-8-3-4-8/h1-2,5-8H,3-4H2,(H,21,24) ODAFRXCOAOWBOU-UHFFFAOYSA-N 355764 3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 41 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 100.0 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355764 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355764&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342969 386395368 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703531 Fc1cc(c(F)cc1Cl)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H11ClF2N4O/c17-9-6-11(19)13(7-10(9)18)23-14-12(2-1-5-20-14)22-15(23)16(24)21-8-3-4-8/h1-2,5-8H,3-4H2,(H,21,24) ODAFRXCOAOWBOU-UHFFFAOYSA-N 355764 3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 41 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 1170 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355764 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355764&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342969 386395368 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703532 O=C(NC1CC1)c1nc2cccnc2n1-c1ccc(cc1)C#N InChI=1S/C17H13N5O/c18-10-11-3-7-13(8-4-11)22-15-14(2-1-9-19-15)21-16(22)17(23)20-12-5-6-12/h1-4,7-9,12H,5-6H2,(H,20,23) QGGYCUZPTGIELD-UHFFFAOYSA-N 355765 3-(4-Cyanophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 42 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 276 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355765 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355765&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343063 386395369 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703533 O=C(NC1CC1)c1nc2cccnc2n1-c1ccc(cc1)C#N InChI=1S/C17H13N5O/c18-10-11-3-7-13(8-4-11)22-15-14(2-1-9-19-15)21-16(22)17(23)20-12-5-6-12/h1-4,7-9,12H,5-6H2,(H,20,23) QGGYCUZPTGIELD-UHFFFAOYSA-N 355765 3-(4-Cyanophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 42 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >22400 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355765 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355765&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343063 386395369 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703534 Fc1ccc(c(F)c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12F2N4O/c17-9-3-6-13(11(18)8-9)22-14-12(2-1-7-19-14)21-15(22)16(23)20-10-4-5-10/h1-3,6-8,10H,4-5H2,(H,20,23) AMMNNNSHVAHTDB-UHFFFAOYSA-N 355766 N-Cyclopropyl-3-(2,4-difluorophenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 43 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 927 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355766&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342823 386395370 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703535 Fc1ccc(c(F)c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12F2N4O/c17-9-3-6-13(11(18)8-9)22-14-12(2-1-7-19-14)21-15(22)16(23)20-10-4-5-10/h1-3,6-8,10H,4-5H2,(H,20,23) AMMNNNSHVAHTDB-UHFFFAOYSA-N 355766 N-Cyclopropyl-3-(2,4-difluorophenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 43 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >26600 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355766&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342823 386395370 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703536 Cc1ccc(F)cc1-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15FN4O/c1-10-4-5-11(18)9-14(10)22-15-13(3-2-8-19-15)21-16(22)17(23)20-12-6-7-12/h2-5,8-9,12H,6-7H2,1H3,(H,20,23) LHBVGROBOMZQQQ-UHFFFAOYSA-N 355767 N-Cyclopropyl-3-(5-fluoro-2-methylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 44 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 1660 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355767 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355767&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343460 386395371 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703537 Cc1ccc(F)cc1-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15FN4O/c1-10-4-5-11(18)9-14(10)22-15-13(3-2-8-19-15)21-16(22)17(23)20-12-6-7-12/h2-5,8-9,12H,6-7H2,1H3,(H,20,23) LHBVGROBOMZQQQ-UHFFFAOYSA-N 355767 N-Cyclopropyl-3-(5-fluoro-2-methylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 44 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >29000 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355767 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355767&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343460 386395371 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703538 COc1ccc(cc1F)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15FN4O2/c1-24-14-7-6-11(9-12(14)18)22-15-13(3-2-8-19-15)21-16(22)17(23)20-10-4-5-10/h2-3,6-10H,4-5H2,1H3,(H,20,23) CTIFTNSATDMQFB-UHFFFAOYSA-N 355768 N-Cyclopropyl-3-(3-fluoro-4-methoxyphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 45 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 205 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355768 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355768&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342899 386395372 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703539 COc1ccc(cc1F)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15FN4O2/c1-24-14-7-6-11(9-12(14)18)22-15-13(3-2-8-19-15)21-16(22)17(23)20-10-4-5-10/h2-3,6-10H,4-5H2,1H3,(H,20,23) CTIFTNSATDMQFB-UHFFFAOYSA-N 355768 N-Cyclopropyl-3-(3-fluoro-4-methoxyphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 45 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 14800 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355768 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355768&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342899 386395372 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703540 COc1cccc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H16N4O2/c1-23-13-5-2-4-12(10-13)21-15-14(6-3-9-18-15)20-16(21)17(22)19-11-7-8-11/h2-6,9-11H,7-8H2,1H3,(H,19,22) AUTAIGJFMSJNMR-UHFFFAOYSA-N 355769 N-Cyclopropyl-3-(3-methoxyphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 46 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 329 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355769 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355769&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343155 386395373 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703541 COc1cccc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H16N4O2/c1-23-13-5-2-4-12(10-13)21-15-14(6-3-9-18-15)20-16(21)17(22)19-11-7-8-11/h2-6,9-11H,7-8H2,1H3,(H,19,22) AUTAIGJFMSJNMR-UHFFFAOYSA-N 355769 N-Cyclopropyl-3-(3-methoxyphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 46 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 13800 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355769 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355769&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343155 386395373 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703542 O=C(NC1CC1)c1nc2cccnc2n1C1Cc2ccccc2C1 InChI=1S/C19H18N4O/c24-19(21-14-7-8-14)18-22-16-6-3-9-20-17(16)23(18)15-10-12-4-1-2-5-13(12)11-15/h1-6,9,14-15H,7-8,10-11H2,(H,21,24) NDIWSQMLTOTSFD-UHFFFAOYSA-N 355770 N-Cyclopropyl-3-(2,3-dihydro-1H-inden-2-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 47 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 1260 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355770 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355770&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343163 386395374 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703543 O=C(NC1CC1)c1nc2cccnc2n1C1Cc2ccccc2C1 InChI=1S/C19H18N4O/c24-19(21-14-7-8-14)18-22-16-6-3-9-20-17(16)23(18)15-10-12-4-1-2-5-13(12)11-15/h1-6,9,14-15H,7-8,10-11H2,(H,21,24) NDIWSQMLTOTSFD-UHFFFAOYSA-N 355770 N-Cyclopropyl-3-(2,3-dihydro-1H-inden-2-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 47 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 6390 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355770 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355770&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343163 386395374 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703544 Fc1cc(F)cc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12F2N4O/c17-9-6-10(18)8-12(7-9)22-14-13(2-1-5-19-14)21-15(22)16(23)20-11-3-4-11/h1-2,5-8,11H,3-4H2,(H,20,23) LVACPSMSGFBDPA-UHFFFAOYSA-N 355771 N-Cyclopropyl-3-(3,5-difluorophenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 48 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 88.9 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355771 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355771&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342793 386395375 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703545 Fc1cc(F)cc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12F2N4O/c17-9-6-10(18)8-12(7-9)22-14-13(2-1-5-19-14)21-15(22)16(23)20-11-3-4-11/h1-2,5-8,11H,3-4H2,(H,20,23) LVACPSMSGFBDPA-UHFFFAOYSA-N 355771 N-Cyclopropyl-3-(3,5-difluorophenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 48 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 4820 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355771 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355771&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342793 386395375 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703546 COc1ccc(cc1Cl)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15ClN4O2/c1-24-14-7-6-11(9-12(14)18)22-15-13(3-2-8-19-15)21-16(22)17(23)20-10-4-5-10/h2-3,6-10H,4-5H2,1H3,(H,20,23) CCBUQTNQXJNWKW-UHFFFAOYSA-N 355772 3-(3-Chloro-4-methoxyphenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 49 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 629 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355772 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355772&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342991 386395376 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703547 COc1ccc(cc1Cl)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15ClN4O2/c1-24-14-7-6-11(9-12(14)18)22-15-13(3-2-8-19-15)21-16(22)17(23)20-10-4-5-10/h2-3,6-10H,4-5H2,1H3,(H,20,23) CCBUQTNQXJNWKW-UHFFFAOYSA-N 355772 3-(3-Chloro-4-methoxyphenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 49 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 12300 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355772 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355772&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342991 386395376 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703548 COc1cc(ccc1C)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C18H18N4O2/c1-11-5-8-13(10-15(11)24-2)22-16-14(4-3-9-19-16)21-17(22)18(23)20-12-6-7-12/h3-5,8-10,12H,6-7H2,1-2H3,(H,20,23) JPLYCESIYFWLBN-UHFFFAOYSA-N 355773 N-Cyclopropyl-3-(3-methoxy-4-methylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 50 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 339 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355773 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355773&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342738 386395377 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703549 COc1cc(ccc1C)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C18H18N4O2/c1-11-5-8-13(10-15(11)24-2)22-16-14(4-3-9-19-16)21-17(22)18(23)20-12-6-7-12/h3-5,8-10,12H,6-7H2,1-2H3,(H,20,23) JPLYCESIYFWLBN-UHFFFAOYSA-N 355773 N-Cyclopropyl-3-(3-methoxy-4-methylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 50 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >30000 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355773 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355773&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342738 386395377 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703550 COc1ccc(cc1C)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C18H18N4O2/c1-11-10-13(7-8-15(11)24-2)22-16-14(4-3-9-19-16)21-17(22)18(23)20-12-5-6-12/h3-4,7-10,12H,5-6H2,1-2H3,(H,20,23) ALVBZWLEHWMUKS-UHFFFAOYSA-N 355774 N-Cyclopropyl-3-(4-methoxy-3-methylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 51 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 207 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355774 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355774&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343143 386395378 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703551 COc1ccc(cc1C)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C18H18N4O2/c1-11-10-13(7-8-15(11)24-2)22-16-14(4-3-9-19-16)21-17(22)18(23)20-12-5-6-12/h3-4,7-10,12H,5-6H2,1-2H3,(H,20,23) ALVBZWLEHWMUKS-UHFFFAOYSA-N 355774 N-Cyclopropyl-3-(4-methoxy-3-methylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 51 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 13200 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355774 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355774&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343143 386395378 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703552 Cc1ccc(cc1C)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C18H18N4O/c1-11-5-8-14(10-12(11)2)22-16-15(4-3-9-19-16)21-17(22)18(23)20-13-6-7-13/h3-5,8-10,13H,6-7H2,1-2H3,(H,20,23) KXLSIGPBLMYYER-UHFFFAOYSA-N 355775 N-Cyclopropyl-3-(3,4-dimethylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 52 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 271 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355775 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355775&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343145 386395379 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703553 Cc1ccc(cc1C)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C18H18N4O/c1-11-5-8-14(10-12(11)2)22-16-15(4-3-9-19-16)21-17(22)18(23)20-13-6-7-13/h3-5,8-10,13H,6-7H2,1-2H3,(H,20,23) KXLSIGPBLMYYER-UHFFFAOYSA-N 355775 N-Cyclopropyl-3-(3,4-dimethylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 52 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 25800 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355775 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355775&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343145 386395379 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703554 O=C(NC1CC1)c1nc2cccnc2n1-c1cccc(c1)C#N InChI=1S/C17H13N5O/c18-10-11-3-1-4-13(9-11)22-15-14(5-2-8-19-15)21-16(22)17(23)20-12-6-7-12/h1-5,8-9,12H,6-7H2,(H,20,23) CROOPLYTQGQYIA-UHFFFAOYSA-N 355776 3-(3-Cyanophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 53 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 287 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355776 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355776&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342612 386395380 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703555 O=C(NC1CC1)c1nc2cccnc2n1-c1cccc(c1)C#N InChI=1S/C17H13N5O/c18-10-11-3-1-4-13(9-11)22-15-14(5-2-8-19-15)21-16(22)17(23)20-12-6-7-12/h1-5,8-9,12H,6-7H2,(H,20,23) CROOPLYTQGQYIA-UHFFFAOYSA-N 355776 3-(3-Cyanophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 53 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 3400 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355776 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355776&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342612 386395380 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703556 Cc1ccc(Cl)cc1-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15ClN4O/c1-10-4-5-11(18)9-14(10)22-15-13(3-2-8-19-15)21-16(22)17(23)20-12-6-7-12/h2-5,8-9,12H,6-7H2,1H3,(H,20,23) HJNYSJXAWWHSTC-UHFFFAOYSA-N 355777 3-(5-Chloro-2-methylphenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 54 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 329 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355777 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355777&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343227 386395381 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703557 Cc1ccc(Cl)cc1-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15ClN4O/c1-10-4-5-11(18)9-14(10)22-15-13(3-2-8-19-15)21-16(22)17(23)20-12-6-7-12/h2-5,8-9,12H,6-7H2,1H3,(H,20,23) HJNYSJXAWWHSTC-UHFFFAOYSA-N 355777 3-(5-Chloro-2-methylphenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 54 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 19200 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355777 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355777&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343227 386395381 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703558 COc1cc(ccc1F)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15FN4O2/c1-24-14-9-11(6-7-12(14)18)22-15-13(3-2-8-19-15)21-16(22)17(23)20-10-4-5-10/h2-3,6-10H,4-5H2,1H3,(H,20,23) IVTRERZZWGCJCM-UHFFFAOYSA-N 355778 N-Cyclopropyl-3-(4-fluoro-3-methoxyphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 55 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 304 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355778 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355778&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342984 386395382 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703559 COc1cc(ccc1F)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15FN4O2/c1-24-14-9-11(6-7-12(14)18)22-15-13(3-2-8-19-15)21-16(22)17(23)20-10-4-5-10/h2-3,6-10H,4-5H2,1H3,(H,20,23) IVTRERZZWGCJCM-UHFFFAOYSA-N 355778 N-Cyclopropyl-3-(4-fluoro-3-methoxyphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 55 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >23700 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355778 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355778&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342984 386395382 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703560 Cc1ccc(cc1C#N)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C18H15N5O/c1-11-4-7-14(9-12(11)10-19)23-16-15(3-2-8-20-16)22-17(23)18(24)21-13-5-6-13/h2-4,7-9,13H,5-6H2,1H3,(H,21,24) XOBOOYYZXQJNOA-UHFFFAOYSA-N 355779 3-(3-Cyano-4-methylphenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 56 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 167 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355779 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355779&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342719 386395383 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703561 Cc1ccc(cc1C#N)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C18H15N5O/c1-11-4-7-14(9-12(11)10-19)23-16-15(3-2-8-20-16)22-17(23)18(24)21-13-5-6-13/h2-4,7-9,13H,5-6H2,1H3,(H,21,24) XOBOOYYZXQJNOA-UHFFFAOYSA-N 355779 3-(3-Cyano-4-methylphenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 56 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 4850 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355779 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355779&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342719 386395383 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703562 O=C(NC1CC1)c1nc2cccnc2n1-c1ccccc1 InChI=1S/C16H14N4O/c21-16(18-11-8-9-11)15-19-13-7-4-10-17-14(13)20(15)12-5-2-1-3-6-12/h1-7,10-11H,8-9H2,(H,18,21) WBGIIMVPDRLBSS-UHFFFAOYSA-N 355780 N-Cyclopropyl-3-phenyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 57 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 1160 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355780 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355780&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342808 386395384 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703563 O=C(NC1CC1)c1nc2cccnc2n1-c1ccccc1 InChI=1S/C16H14N4O/c21-16(18-11-8-9-11)15-19-13-7-4-10-17-14(13)20(15)12-5-2-1-3-6-12/h1-7,10-11H,8-9H2,(H,18,21) WBGIIMVPDRLBSS-UHFFFAOYSA-N 355780 N-Cyclopropyl-3-phenyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 57 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >19700 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355780 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355780&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342808 386395384 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703564 COc1ccc(cc1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H16N4O2/c1-23-13-8-6-12(7-9-13)21-15-14(3-2-10-18-15)20-16(21)17(22)19-11-4-5-11/h2-3,6-11H,4-5H2,1H3,(H,19,22) PYQDVXHOGXBBFR-UHFFFAOYSA-N 355781 N-Cyclopropyl-3-(4-methoxyphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 58 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 506 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355781 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355781&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342508 386395385 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703565 COc1ccc(cc1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H16N4O2/c1-23-13-8-6-12(7-9-13)21-15-14(3-2-10-18-15)20-16(21)17(22)19-11-4-5-11/h2-3,6-11H,4-5H2,1H3,(H,19,22) PYQDVXHOGXBBFR-UHFFFAOYSA-N 355781 N-Cyclopropyl-3-(4-methoxyphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 58 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >30000 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355781 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355781&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342508 386395385 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703566 Cc1ccc(c(C)c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C18H18N4O/c1-11-5-8-15(12(2)10-11)22-16-14(4-3-9-19-16)21-17(22)18(23)20-13-6-7-13/h3-5,8-10,13H,6-7H2,1-2H3,(H,20,23) WALJCQLGLIMIHG-UHFFFAOYSA-N 355782 N-Cyclopropyl-3-(2,4-dimethylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 59 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 1020 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355782 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355782&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342685 386395386 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703567 Cc1ccc(c(C)c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C18H18N4O/c1-11-5-8-15(12(2)10-11)22-16-14(4-3-9-19-16)21-17(22)18(23)20-13-6-7-13/h3-5,8-10,13H,6-7H2,1-2H3,(H,20,23) WALJCQLGLIMIHG-UHFFFAOYSA-N 355782 N-Cyclopropyl-3-(2,4-dimethylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 59 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >30000 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355782 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355782&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342685 386395386 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703568 Cc1cc(F)ccc1-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15FN4O/c1-10-9-11(18)4-7-14(10)22-15-13(3-2-8-19-15)21-16(22)17(23)20-12-5-6-12/h2-4,7-9,12H,5-6H2,1H3,(H,20,23) FAXWTOOMQLLKRG-UHFFFAOYSA-N 355783 N-Cyclopropyl-3-(4-fluoro-2-methylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 60 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 1200 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355783 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355783&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343377 386395387 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703569 Cc1cc(F)ccc1-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15FN4O/c1-10-9-11(18)4-7-14(10)22-15-13(3-2-8-19-15)21-16(22)17(23)20-12-5-6-12/h2-4,7-9,12H,5-6H2,1H3,(H,20,23) FAXWTOOMQLLKRG-UHFFFAOYSA-N 355783 N-Cyclopropyl-3-(4-fluoro-2-methylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 60 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >30000 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355783 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355783&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343377 386395387 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703570 O=C(NC1CC1)c1nc2cccnc2n1-c1ccc2COCc2c1 InChI=1S/C18H16N4O2/c23-18(20-13-4-5-13)17-21-15-2-1-7-19-16(15)22(17)14-6-3-11-9-24-10-12(11)8-14/h1-3,6-8,13H,4-5,9-10H2,(H,20,23) CBYDRXNBBZURMU-UHFFFAOYSA-N 355784 N-Cyclopropyl-3-(1,3-dihydro-2-benzofuran-5-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 61 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 1580 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355784 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355784&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342677 386395388 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703571 O=C(NC1CC1)c1nc2cccnc2n1-c1ccc2COCc2c1 InChI=1S/C18H16N4O2/c23-18(20-13-4-5-13)17-21-15-2-1-7-19-16(15)22(17)14-6-3-11-9-24-10-12(11)8-14/h1-3,6-8,13H,4-5,9-10H2,(H,20,23) CBYDRXNBBZURMU-UHFFFAOYSA-N 355784 N-Cyclopropyl-3-(1,3-dihydro-2-benzofuran-5-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 61 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >30000 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355784 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355784&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342677 386395388 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703572 Fc1ccc(cc1F)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12F2N4O/c17-11-6-5-10(8-12(11)18)22-14-13(2-1-7-19-14)21-15(22)16(23)20-9-3-4-9/h1-2,5-9H,3-4H2,(H,20,23) JFSPBVQCMFSJPK-UHFFFAOYSA-N 355785 N-Cyclopropyl-3-(3,4-difluorophenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 62 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 34.9 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355785 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355785&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343563 386395389 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703573 Fc1ccc(cc1F)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12F2N4O/c17-11-6-5-10(8-12(11)18)22-14-13(2-1-7-19-14)21-15(22)16(23)20-9-3-4-9/h1-2,5-9H,3-4H2,(H,20,23) JFSPBVQCMFSJPK-UHFFFAOYSA-N 355785 N-Cyclopropyl-3-(3,4-difluorophenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 62 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 1490 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355785 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355785&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343563 386395389 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703574 Clc1cc(Cl)cc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12Cl2N4O/c17-9-6-10(18)8-12(7-9)22-14-13(2-1-5-19-14)21-15(22)16(23)20-11-3-4-11/h1-2,5-8,11H,3-4H2,(H,20,23) YKJCYZPRBWPNPW-UHFFFAOYSA-N 355786 N-Cyclopropyl-3-(3,5-dichlorophenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 63 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 68.0 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355786 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355786&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342981 386395390 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703575 Clc1cc(Cl)cc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12Cl2N4O/c17-9-6-10(18)8-12(7-9)22-14-13(2-1-5-19-14)21-15(22)16(23)20-11-3-4-11/h1-2,5-8,11H,3-4H2,(H,20,23) YKJCYZPRBWPNPW-UHFFFAOYSA-N 355786 N-Cyclopropyl-3-(3,5-dichlorophenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 63 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 2550 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355786 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355786&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342981 386395390 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703576 O=C(NC1CC1)c1nc2cccnc2n1-c1ccc2CCCc2c1 InChI=1S/C19H18N4O/c24-19(21-14-7-8-14)18-22-16-5-2-10-20-17(16)23(18)15-9-6-12-3-1-4-13(12)11-15/h2,5-6,9-11,14H,1,3-4,7-8H2,(H,21,24) IKSFLILQDWZZLV-UHFFFAOYSA-N 355787 N-Cyclopropyl-3-(2,3-dihydro-1H-inden-5-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 64 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 206 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355787 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355787&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343008 386395391 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703577 O=C(NC1CC1)c1nc2cccnc2n1-c1ccc2CCCc2c1 InChI=1S/C19H18N4O/c24-19(21-14-7-8-14)18-22-16-5-2-10-20-17(16)23(18)15-9-6-12-3-1-4-13(12)11-15/h2,5-6,9-11,14H,1,3-4,7-8H2,(H,21,24) IKSFLILQDWZZLV-UHFFFAOYSA-N 355787 N-Cyclopropyl-3-(2,3-dihydro-1H-inden-5-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 64 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 15700 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355787 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355787&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343008 386395391 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703578 Fc1cccc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H13FN4O/c17-10-3-1-4-12(9-10)21-14-13(5-2-8-18-14)20-15(21)16(22)19-11-6-7-11/h1-5,8-9,11H,6-7H2,(H,19,22) CLDQUNCNPINXQM-UHFFFAOYSA-N 355788 N-Cyclopropyl-3-(3-fluorophenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 65 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 188 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355788 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355788&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343000 386395392 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703579 Fc1cccc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H13FN4O/c17-10-3-1-4-12(9-10)21-14-13(5-2-8-18-14)20-15(21)16(22)19-11-6-7-11/h1-5,8-9,11H,6-7H2,(H,19,22) CLDQUNCNPINXQM-UHFFFAOYSA-N 355788 N-Cyclopropyl-3-(3-fluorophenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 65 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 10900 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355788 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355788&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343000 386395392 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703580 COc1cc(OC)cc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C18H18N4O3/c1-24-13-8-12(9-14(10-13)25-2)22-16-15(4-3-7-19-16)21-17(22)18(23)20-11-5-6-11/h3-4,7-11H,5-6H2,1-2H3,(H,20,23) OHPZBSBGFJPXQP-UHFFFAOYSA-N 355789 N-Cyclopropyl-3-(3,5-dimethoxyphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 66 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 759 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355789 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355789&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343487 386395393 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703581 COc1cc(OC)cc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C18H18N4O3/c1-24-13-8-12(9-14(10-13)25-2)22-16-15(4-3-7-19-16)21-17(22)18(23)20-11-5-6-11/h3-4,7-11H,5-6H2,1-2H3,(H,20,23) OHPZBSBGFJPXQP-UHFFFAOYSA-N 355789 N-Cyclopropyl-3-(3,5-dimethoxyphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 66 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 19400 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355789 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355789&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343487 386395393 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703582 Cc1ccc(c(F)c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15FN4O/c1-10-4-7-14(12(18)9-10)22-15-13(3-2-8-19-15)21-16(22)17(23)20-11-5-6-11/h2-4,7-9,11H,5-6H2,1H3,(H,20,23) BFLVMXOBIPQPRT-UHFFFAOYSA-N 355790 N-Cyclopropyl-3-(2-fluoro-4-methylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 67 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 619 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355790 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355790&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342731 386395394 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703583 Cc1ccc(c(F)c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15FN4O/c1-10-4-7-14(12(18)9-10)22-15-13(3-2-8-19-15)21-16(22)17(23)20-11-5-6-11/h2-4,7-9,11H,5-6H2,1H3,(H,20,23) BFLVMXOBIPQPRT-UHFFFAOYSA-N 355790 N-Cyclopropyl-3-(2-fluoro-4-methylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 67 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >30000 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355790 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355790&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342731 386395394 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703584 Fc1ccc(cc1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H13FN4O/c17-10-3-7-12(8-4-10)21-14-13(2-1-9-18-14)20-15(21)16(22)19-11-5-6-11/h1-4,7-9,11H,5-6H2,(H,19,22) VXOZXGHOYRHTAZ-UHFFFAOYSA-N 355791 N-Cyclopropyl-3-(4-fluorophenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 68 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 219 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355791 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355791&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342807 386395395 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703585 Fc1ccc(cc1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H13FN4O/c17-10-3-7-12(8-4-10)21-14-13(2-1-9-18-14)20-15(21)16(22)19-11-5-6-11/h1-4,7-9,11H,5-6H2,(H,19,22) VXOZXGHOYRHTAZ-UHFFFAOYSA-N 355791 N-Cyclopropyl-3-(4-fluorophenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 68 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 11900 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355791 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355791&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342807 386395395 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703586 Clc1cccc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H13ClN4O/c17-10-3-1-4-12(9-10)21-14-13(5-2-8-18-14)20-15(21)16(22)19-11-6-7-11/h1-5,8-9,11H,6-7H2,(H,19,22) UROYTKATDVCEMT-UHFFFAOYSA-N 355792 3-(3-Chlorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 69 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 70.9 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355792 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355792&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342704 386395396 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703587 Clc1cccc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H13ClN4O/c17-10-3-1-4-12(9-10)21-14-13(5-2-8-18-14)20-15(21)16(22)19-11-6-7-11/h1-5,8-9,11H,6-7H2,(H,19,22) UROYTKATDVCEMT-UHFFFAOYSA-N 355792 3-(3-Chlorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 69 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 1910 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355792 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355792&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342704 386395396 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703588 Cc1cccc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H16N4O/c1-11-4-2-5-13(10-11)21-15-14(6-3-9-18-15)20-16(21)17(22)19-12-7-8-12/h2-6,9-10,12H,7-8H2,1H3,(H,19,22) HYSFNLWPNNMOSG-UHFFFAOYSA-N 355793 N-Cyclopropyl-3-(3-methylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 70 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 421 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355793&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342849 386395397 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703589 Cc1cccc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H16N4O/c1-11-4-2-5-13(10-11)21-15-14(6-3-9-18-15)20-16(21)17(22)19-12-7-8-12/h2-6,9-10,12H,7-8H2,1H3,(H,19,22) HYSFNLWPNNMOSG-UHFFFAOYSA-N 355793 N-Cyclopropyl-3-(3-methylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 70 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 14900 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355793&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342849 386395397 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703590 O=C(NC1CC1)c1nc2cccnc2n1-c1ccc2ncsc2c1 InChI=1S/C17H13N5OS/c23-17(20-10-3-4-10)16-21-13-2-1-7-18-15(13)22(16)11-5-6-12-14(8-11)24-9-19-12/h1-2,5-10H,3-4H2,(H,20,23) RIMSLYGHGHUFCL-UHFFFAOYSA-N 355794 3-(1,3-Benzothiazol-6-yl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 71 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 155 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355794 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355794&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342987 386395398 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703591 O=C(NC1CC1)c1nc2cccnc2n1-c1ccc2ncsc2c1 InChI=1S/C17H13N5OS/c23-17(20-10-3-4-10)16-21-13-2-1-7-18-15(13)22(16)11-5-6-12-14(8-11)24-9-19-12/h1-2,5-10H,3-4H2,(H,20,23) RIMSLYGHGHUFCL-UHFFFAOYSA-N 355794 3-(1,3-Benzothiazol-6-yl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 71 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 6340 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355794 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355794&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342987 386395398 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703592 CSc1cccc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H16N4OS/c1-23-13-5-2-4-12(10-13)21-15-14(6-3-9-18-15)20-16(21)17(22)19-11-7-8-11/h2-6,9-11H,7-8H2,1H3,(H,19,22) PEDUGVYHTYHXBE-UHFFFAOYSA-N 355795 N-Cyclopropyl-3-[3-(methylsulfanyl)phenyl]-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 72 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 40.9 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355795 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355795&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343131 386395399 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703593 CSc1cccc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H16N4OS/c1-23-13-5-2-4-12(10-13)21-15-14(6-3-9-18-15)20-16(21)17(22)19-11-7-8-11/h2-6,9-11H,7-8H2,1H3,(H,19,22) PEDUGVYHTYHXBE-UHFFFAOYSA-N 355795 N-Cyclopropyl-3-[3-(methylsulfanyl)phenyl]-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 72 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 753 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355795 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355795&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343131 386395399 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703594 Cc1nc2ccc(cc2s1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C18H15N5OS/c1-10-20-13-7-6-12(9-15(13)25-10)23-16-14(3-2-8-19-16)22-17(23)18(24)21-11-4-5-11/h2-3,6-9,11H,4-5H2,1H3,(H,21,24) SINVIAMKDOUHGF-UHFFFAOYSA-N 355796 N-Cyclopropyl-3-(2-methyl-1,3-benzothiazol-6-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 73 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 516 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355796 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355796&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343497 386395400 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703595 Cc1nc2ccc(cc2s1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C18H15N5OS/c1-10-20-13-7-6-12(9-15(13)25-10)23-16-14(3-2-8-19-16)22-17(23)18(24)21-11-4-5-11/h2-3,6-9,11H,4-5H2,1H3,(H,21,24) SINVIAMKDOUHGF-UHFFFAOYSA-N 355796 N-Cyclopropyl-3-(2-methyl-1,3-benzothiazol-6-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 73 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 12600 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355796 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355796&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343497 386395400 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703596 Cc1cc(ccc1Cl)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15ClN4O/c1-10-9-12(6-7-13(10)18)22-15-14(3-2-8-19-15)21-16(22)17(23)20-11-4-5-11/h2-3,6-9,11H,4-5H2,1H3,(H,20,23) UIEQXINHCWKXNT-UHFFFAOYSA-N 355797 3-(4-Chloro-3-methylphenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 74 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 58.8 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355797 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355797&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342983 386395401 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703597 Cc1cc(ccc1Cl)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15ClN4O/c1-10-9-12(6-7-13(10)18)22-15-14(3-2-8-19-15)21-16(22)17(23)20-11-4-5-11/h2-3,6-9,11H,4-5H2,1H3,(H,20,23) UIEQXINHCWKXNT-UHFFFAOYSA-N 355797 3-(4-Chloro-3-methylphenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 74 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 1990 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355797 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355797&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342983 386395401 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703598 FC(F)(F)Oc1cccc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H13F3N4O2/c18-17(19,20)26-12-4-1-3-11(9-12)24-14-13(5-2-8-21-14)23-15(24)16(25)22-10-6-7-10/h1-5,8-10H,6-7H2,(H,22,25) BZDJCNHJFHOZGZ-UHFFFAOYSA-N 355798 N-Cyclopropyl-3-[3-(trifluoromethoxy)phenyl]-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 75 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 389 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355798 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355798&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343036 386395402 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703599 FC(F)(F)Oc1cccc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H13F3N4O2/c18-17(19,20)26-12-4-1-3-11(9-12)24-14-13(5-2-8-21-14)23-15(24)16(25)22-10-6-7-10/h1-5,8-10H,6-7H2,(H,22,25) BZDJCNHJFHOZGZ-UHFFFAOYSA-N 355798 N-Cyclopropyl-3-[3-(trifluoromethoxy)phenyl]-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 75 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 3980 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355798 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355798&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343036 386395402 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703600 Cc1cc(C)cc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C18H18N4O/c1-11-8-12(2)10-14(9-11)22-16-15(4-3-7-19-16)21-17(22)18(23)20-13-5-6-13/h3-4,7-10,13H,5-6H2,1-2H3,(H,20,23) WKAAYWUHBSOTIG-UHFFFAOYSA-N 355799 N-Cyclopropyl-3-(3,5-dimethylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 76 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 374 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355799&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342949 386395403 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703601 Cc1cc(C)cc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C18H18N4O/c1-11-8-12(2)10-14(9-11)22-16-15(4-3-7-19-16)21-17(22)18(23)20-13-5-6-13/h3-4,7-10,13H,5-6H2,1-2H3,(H,20,23) WKAAYWUHBSOTIG-UHFFFAOYSA-N 355799 N-Cyclopropyl-3-(3,5-dimethylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 76 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >18800 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355799&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342949 386395403 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703602 FC(F)(F)c1cccc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H13F3N4O/c18-17(19,20)10-3-1-4-12(9-10)24-14-13(5-2-8-21-14)23-15(24)16(25)22-11-6-7-11/h1-5,8-9,11H,6-7H2,(H,22,25) HANFIAMZGOGGMF-UHFFFAOYSA-N 355800 N-Cyclopropyl-3-[3-(trifluoromethyl)phenyl]-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 77 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 1150 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355800 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355800&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342630 386395404 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703603 FC(F)(F)c1cccc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H13F3N4O/c18-17(19,20)10-3-1-4-12(9-10)24-14-13(5-2-8-21-14)23-15(24)16(25)22-11-6-7-11/h1-5,8-9,11H,6-7H2,(H,22,25) HANFIAMZGOGGMF-UHFFFAOYSA-N 355800 N-Cyclopropyl-3-[3-(trifluoromethyl)phenyl]-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 77 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 8640 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355800 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355800&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342630 386395404 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703604 Fc1c(Cl)cccc1-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12ClFN4O/c17-10-3-1-5-12(13(10)18)22-14-11(4-2-8-19-14)21-15(22)16(23)20-9-6-7-9/h1-5,8-9H,6-7H2,(H,20,23) FOYDTAGOBRGLHB-UHFFFAOYSA-N 355801 3-(3-Chloro-2-fluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide, trifluoroacetate salt::US9815832, 78 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 387 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355801 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355801&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90352325 386395405 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703605 Fc1c(Cl)cccc1-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12ClFN4O/c17-10-3-1-5-12(13(10)18)22-14-11(4-2-8-19-14)21-15(22)16(23)20-9-6-7-9/h1-5,8-9H,6-7H2,(H,20,23) FOYDTAGOBRGLHB-UHFFFAOYSA-N 355801 3-(3-Chloro-2-fluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide, trifluoroacetate salt::US9815832, 78 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 11400 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355801 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355801&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90352325 386395405 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703606 Fc1ccc(Cl)cc1-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12ClFN4O/c17-9-3-6-11(18)13(8-9)22-14-12(2-1-7-19-14)21-15(22)16(23)20-10-4-5-10/h1-3,6-8,10H,4-5H2,(H,20,23) WIYIQZWDBJZSMW-UHFFFAOYSA-N 355802 3-(5-Chloro-2-fluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide, trifluoroacetate salt::US9815832, 79 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 106 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355802 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355802&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90352326 386395406 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703607 Fc1ccc(Cl)cc1-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12ClFN4O/c17-9-3-6-11(18)13(8-9)22-14-12(2-1-7-19-14)21-15(22)16(23)20-10-4-5-10/h1-3,6-8,10H,4-5H2,(H,20,23) WIYIQZWDBJZSMW-UHFFFAOYSA-N 355802 3-(5-Chloro-2-fluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide, trifluoroacetate salt::US9815832, 79 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 1760 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355802 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355802&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90352326 386395406 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703608 O=C(NC1CC1)c1nc2cccnc2n1-c1ccc2ncccc2c1 InChI=1S/C19H15N5O/c25-19(22-13-5-6-13)18-23-16-4-2-10-21-17(16)24(18)14-7-8-15-12(11-14)3-1-9-20-15/h1-4,7-11,13H,5-6H2,(H,22,25) VXFYGAJFGQCBAY-UHFFFAOYSA-N 355803 N-Cyclopropyl-3-(quinolin-6-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide,trifluoroacetate salt::US9815832, 80 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 1470 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355803 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355803&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90352327 386395407 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703609 O=C(NC1CC1)c1nc2cccnc2n1-c1ccc2ncccc2c1 InChI=1S/C19H15N5O/c25-19(22-13-5-6-13)18-23-16-4-2-10-21-17(16)24(18)14-7-8-15-12(11-14)3-1-9-20-15/h1-4,7-11,13H,5-6H2,(H,22,25) VXFYGAJFGQCBAY-UHFFFAOYSA-N 355803 N-Cyclopropyl-3-(quinolin-6-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide,trifluoroacetate salt::US9815832, 80 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >30000 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355803 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355803&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90352327 386395407 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703610 CCNC(=O)c1nc2cccnc2n1-c1cncc(Cl)c1 InChI=1S/C14H12ClN5O/c1-2-17-14(21)13-19-11-4-3-5-18-12(11)20(13)10-6-9(15)7-16-8-10/h3-8H,2H2,1H3,(H,17,21) XTHBNWBPBQZQGO-UHFFFAOYSA-N 355804 3-(5-Chloropyridin-3-yl)-N-ethyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 81 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 8270 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355804 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355804&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343272 386395408 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703611 CCNC(=O)c1nc2cccnc2n1-c1cncc(Cl)c1 InChI=1S/C14H12ClN5O/c1-2-17-14(21)13-19-11-4-3-5-18-12(11)20(13)10-6-9(15)7-16-8-10/h3-8H,2H2,1H3,(H,17,21) XTHBNWBPBQZQGO-UHFFFAOYSA-N 355804 3-(5-Chloropyridin-3-yl)-N-ethyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 81 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >30000 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355804 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355804&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343272 386395408 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703612 FC(F)(F)c1cc(ccn1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12F3N5O/c17-16(18,19)12-8-10(5-7-20-12)24-13-11(2-1-6-21-13)23-14(24)15(25)22-9-3-4-9/h1-2,5-9H,3-4H2,(H,22,25) GPUSOJNUPPOYPZ-UHFFFAOYSA-N 355805 N-Cyclopropyl-3-[2-(trifluoromethyl)pyridin-4-yl]-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 82 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 6070 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355805 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355805&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342706 386395409 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703613 FC(F)(F)c1cc(ccn1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12F3N5O/c17-16(18,19)12-8-10(5-7-20-12)24-13-11(2-1-6-21-13)23-14(24)15(25)22-9-3-4-9/h1-2,5-9H,3-4H2,(H,22,25) GPUSOJNUPPOYPZ-UHFFFAOYSA-N 355805 N-Cyclopropyl-3-[2-(trifluoromethyl)pyridin-4-yl]-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 82 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 17500 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355805 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355805&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342706 386395409 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703614 COc1cncc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H15N5O2/c1-23-12-7-11(8-17-9-12)21-14-13(3-2-6-18-14)20-15(21)16(22)19-10-4-5-10/h2-3,6-10H,4-5H2,1H3,(H,19,22) UCLOEBCZXVNVAI-UHFFFAOYSA-N 355806 N-Cyclopropyl-3-(5-methoxypyridin-3-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 83 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 13600 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355806 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355806&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343630 386395410 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703615 COc1cncc(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H15N5O2/c1-23-12-7-11(8-17-9-12)21-14-13(3-2-6-18-14)20-15(21)16(22)19-10-4-5-10/h2-3,6-10H,4-5H2,1H3,(H,19,22) UCLOEBCZXVNVAI-UHFFFAOYSA-N 355806 N-Cyclopropyl-3-(5-methoxypyridin-3-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 83 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >29300 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355806 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355806&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343630 386395410 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703616 Cc1cc(c(Cl)cc1F)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H14ClFN4O/c1-9-7-14(11(18)8-12(9)19)23-15-13(3-2-6-20-15)22-16(23)17(24)21-10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,21,24) WVSKTYGNRIZTKH-UHFFFAOYSA-N 355807 3-(2-Chloro-4-fluoro-5-methylphenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 84 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 16600 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355807 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355807&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90352329 386395411 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703617 Cc1cc(c(Cl)cc1F)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H14ClFN4O/c1-9-7-14(11(18)8-12(9)19)23-15-13(3-2-6-20-15)22-16(23)17(24)21-10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,21,24) WVSKTYGNRIZTKH-UHFFFAOYSA-N 355807 3-(2-Chloro-4-fluoro-5-methylphenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 84 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >30000 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355807 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355807&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90352329 386395411 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703618 Cc1ccc(cn1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H15N5O/c1-10-4-7-12(9-18-10)21-14-13(3-2-8-17-14)20-15(21)16(22)19-11-5-6-11/h2-4,7-9,11H,5-6H2,1H3,(H,19,22) WSAFBIKAPJQZAX-UHFFFAOYSA-N 355808 N-Cyclopropyl-3-(6-methylpyridin-3-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 85 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 7730 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355808 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355808&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342686 386395412 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703619 Cc1ccc(cn1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H15N5O/c1-10-4-7-12(9-18-10)21-14-13(3-2-8-17-14)20-15(21)16(22)19-11-5-6-11/h2-4,7-9,11H,5-6H2,1H3,(H,19,22) WSAFBIKAPJQZAX-UHFFFAOYSA-N 355808 N-Cyclopropyl-3-(6-methylpyridin-3-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 85 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >30000 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355808 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355808&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342686 386395412 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703620 Cn1ncc2ccc(cc12)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C18H16N6O/c1-23-15-9-13(7-4-11(15)10-20-23)24-16-14(3-2-8-19-16)22-17(24)18(25)21-12-5-6-12/h2-4,7-10,12H,5-6H2,1H3,(H,21,25) DPXWTLVJMJAOEA-UHFFFAOYSA-N 355809 N-Cyclopropyl-3-(1-methyl-1H-indazol-6-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 86 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 24500 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355809 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355809&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343055 386395413 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703621 Cn1ncc2ccc(cc12)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C18H16N6O/c1-23-15-9-13(7-4-11(15)10-20-23)24-16-14(3-2-8-19-16)22-17(24)18(25)21-12-5-6-12/h2-4,7-10,12H,5-6H2,1H3,(H,21,25) DPXWTLVJMJAOEA-UHFFFAOYSA-N 355809 N-Cyclopropyl-3-(1-methyl-1H-indazol-6-yl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 86 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >30000 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355809 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355809&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343055 386395413 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703622 COc1ccc(cc1OC)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C18H18N4O3/c1-24-14-8-7-12(10-15(14)25-2)22-16-13(4-3-9-19-16)21-17(22)18(23)20-11-5-6-11/h3-4,7-11H,5-6H2,1-2H3,(H,20,23) GCBIKWRVZPNDHJ-UHFFFAOYSA-N 355810 N-Cyclopropyl-3-(3,4-dimethoxyphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 87 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 2720 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355810 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355810&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343062 386395414 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703623 COc1ccc(cc1OC)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C18H18N4O3/c1-24-14-8-7-12(10-15(14)25-2)22-16-13(4-3-9-19-16)21-17(22)18(23)20-11-5-6-11/h3-4,7-11H,5-6H2,1-2H3,(H,20,23) GCBIKWRVZPNDHJ-UHFFFAOYSA-N 355810 N-Cyclopropyl-3-(3,4-dimethoxyphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 87 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >30000 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355810 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355810&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343062 386395414 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703624 Cc1ccc(c(Cl)c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15ClN4O/c1-10-4-7-14(12(18)9-10)22-15-13(3-2-8-19-15)21-16(22)17(23)20-11-5-6-11/h2-4,7-9,11H,5-6H2,1H3,(H,20,23) ZVEAYTJADBKJJU-UHFFFAOYSA-N 355811 3-(2-Chloro-4-methylphenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 88 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 3700 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355811 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355811&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342797 386395415 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703625 Cc1ccc(c(Cl)c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15ClN4O/c1-10-4-7-14(12(18)9-10)22-15-13(3-2-8-19-15)21-16(22)17(23)20-11-5-6-11/h2-4,7-9,11H,5-6H2,1H3,(H,20,23) ZVEAYTJADBKJJU-UHFFFAOYSA-N 355811 3-(2-Chloro-4-methylphenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 88 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >30000 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355811 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355811&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342797 386395415 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703626 COc1ccc(c(C)c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C18H18N4O2/c1-11-10-13(24-2)7-8-15(11)22-16-14(4-3-9-19-16)21-17(22)18(23)20-12-5-6-12/h3-4,7-10,12H,5-6H2,1-2H3,(H,20,23) GYGNUEYBRCSOQT-UHFFFAOYSA-N 355812 N-Cyclopropyl-3-(4-methoxy-2-methylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 89 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 3520 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355812 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355812&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343641 386395416 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703627 COc1ccc(c(C)c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C18H18N4O2/c1-11-10-13(24-2)7-8-15(11)22-16-14(4-3-9-19-16)21-17(22)18(23)20-12-5-6-12/h3-4,7-10,12H,5-6H2,1-2H3,(H,20,23) GYGNUEYBRCSOQT-UHFFFAOYSA-N 355812 N-Cyclopropyl-3-(4-methoxy-2-methylphenyl)-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 89 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >30000 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355812 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355812&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343641 386395416 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703628 Fc1ccc(Cl)c(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12ClFN4O/c17-11-6-3-9(18)8-13(11)22-14-12(2-1-7-19-14)21-15(22)16(23)20-10-4-5-10/h1-3,6-8,10H,4-5H2,(H,20,23) HOOQBZPAYSBYJB-UHFFFAOYSA-N 355813 3-(2-Chloro-5-fluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 90 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 9230 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355813 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355813&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342999 386395417 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703629 Fc1ccc(Cl)c(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C16H12ClFN4O/c17-11-6-3-9(18)8-13(11)22-14-12(2-1-7-19-14)21-15(22)16(23)20-10-4-5-10/h1-3,6-8,10H,4-5H2,(H,20,23) HOOQBZPAYSBYJB-UHFFFAOYSA-N 355813 3-(2-Chloro-5-fluorophenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 90 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >30000 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355813 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355813&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342999 386395417 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703630 Cc1ccc(Cl)c(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15ClN4O/c1-10-4-7-12(18)14(9-10)22-15-13(3-2-8-19-15)21-16(22)17(23)20-11-5-6-11/h2-4,7-9,11H,5-6H2,1H3,(H,20,23) QKTYRUVKFGGLCF-UHFFFAOYSA-N 355814 3-(2-Chloro-5-methylphenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 91 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 9420 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355814 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355814&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90343110 386395418 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703631 Cc1ccc(Cl)c(c1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H15ClN4O/c1-10-4-7-12(18)14(9-10)22-15-13(3-2-8-19-15)21-16(22)17(23)20-11-5-6-11/h2-4,7-9,11H,5-6H2,1H3,(H,20,23) QKTYRUVKFGGLCF-UHFFFAOYSA-N 355814 3-(2-Chloro-5-methylphenyl)-N-cyclopropyl-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 91 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >30000 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355814 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355814&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90343110 386395418 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 703632 FC(F)(F)c1ccc(cc1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H13F3N4O/c18-17(19,20)10-3-7-12(8-4-10)24-14-13(2-1-9-21-14)23-15(24)16(25)22-11-5-6-11/h1-4,7-9,11H,5-6H2,(H,22,25) IDCKFWYUZXHXDU-UHFFFAOYSA-N 355815 N-Cyclopropyl-3-[4-(trifluoromethyl)phenyl]-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 92 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 3110 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355815 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355815&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 90342803 386395419 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 703633 FC(F)(F)c1ccc(cc1)-n1c(nc2cccnc12)C(=O)NC1CC1 InChI=1S/C17H13F3N4O/c18-17(19,20)10-3-7-12(8-4-10)24-14-13(2-1-9-21-14)23-15(24)16(25)22-11-5-6-11/h1-4,7-9,11H,5-6H2,(H,22,25) IDCKFWYUZXHXDU-UHFFFAOYSA-N 355815 N-Cyclopropyl-3-[4-(trifluoromethyl)phenyl]-3H-imidazo[4,5-b]pyridine-2-carboxamide::US9815832, 92 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human >30000 US Patent 10.7270/Q2G1630T aid1797606 US9815832 Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM 11/14/2017 10/13/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355815 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355815&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 90342803 386395419 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7